skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,498,556  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Article 		Add to My Research

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08766-9 ;PMID: 34556087

Full text available

Citations Cited by
2
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine
Material Type:
Article 		Add to My Research

Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine

Cancer science, 2020-08, Vol.111 (8), p.2708-2717 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;ISSN: 1349-7006 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14537 ;PMID: 32573845

Full text available

Citations Cited by
3
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants
Material Type:
Article 		Add to My Research

Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants

PLoS medicine, 2020-07, Vol.17 (7), p.e1003178 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Larsson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Larsson et al 2020 Larsson et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003178 ;PMID: 32701947

Full text available

Citations Cited by
4
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Material Type:
Article 		Add to My Research

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature

PloS one, 2012-12, Vol.7 (12), p.e50946-e50946 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Zhang et al 2012 Zhang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0050946 ;PMID: 23284651

Full text available

Citations Cited by
5
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Material Type:
Article 		Add to My Research

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1259-z ;PMID: 31196207

Full text available

Citations Cited by
6
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Material Type:
Article 		Add to My Research

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

PloS one, 2013-08, Vol.8 (8), p.e71583 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Franciosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Franciosi et al 2013 Franciosi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0071583 ;PMID: 23936520

Full text available

Citations Cited by
7
Cancer statistics, 2022
Cancer statistics, 2022
Material Type:
Article 		Add to My Research

Cancer statistics, 2022

CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21708 ;PMID: 35020204

Full text available

Citations Cited by
8
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
Material Type:
Article 		Add to My Research

PD-1 blockade inhibits osteoclast formation and murine bone cancer pain

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3603-3620 [Peer Reviewed Journal]

COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jul 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci133334 ;PMID: 32484460

Full text available

Citations Cited by
9
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
Material Type:
Book 		Add to My Research

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode ;ISBN: 9783038975557 ;ISBN: 3038975559 ;ISBN: 9783038975540 ;ISBN: 3038975540 ;DOI: 10.3390/books978-3-03897-555-7

Full text available

Citations Cited by
10
Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
Material Type:
Article 		Add to My Research

Hormone Replacement Therapy in Cancer Survivors – Review of the Literature

Pathology oncology research, 2020-01, Vol.26 (1), p.63-78 [Peer Reviewed Journal]

The Author(s) 2019 ;ISSN: 1219-4956 ;EISSN: 1532-2807 ;DOI: 10.1007/s12253-018-00569-x

Digital Resources/Online E-Resources

Citations Cited by
11
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Material Type:
Article 		Add to My Research

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting

Cell proliferation, 2021-10, Vol.54 (10), p.e13115-n/a [Peer Reviewed Journal]

2021 The Authors. Published by John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0960-7722 ;EISSN: 1365-2184 ;DOI: 10.1111/cpr.13115 ;PMID: 34464477

Full text available

Citations Cited by
12
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Material Type:
Article 		Add to My Research

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667

Full text available

Citations Cited by
13
Long non‑coding RNA GAS5 in human cancer (Review)
Long non‑coding RNA GAS5 in human cancer (Review)
Material Type:
Article 		Add to My Research

Long non‑coding RNA GAS5 in human cancer (Review)

Oncology letters, 2020-09, Vol.20 (3), p.2587-2594

COPYRIGHT 2020 Spandidos Publications ;COPYRIGHT 2020 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2020 ;Copyright: © Yang et al. 2020 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2020.11809 ;PMID: 32782576

Full text available

Citations Cited by
14
Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
Material Type:
Article 		Add to My Research

Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies

The oncologist (Dayton, Ohio), 2023-06, Vol.28 (6), p.e487-e487 [Peer Reviewed Journal]

COPYRIGHT 2023 Oxford University Press ;The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad048 ;PMID: 36821849

Full text available

Citations Cited by
15
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Material Type:
Article 		Add to My Research

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

Molecular cancer, 2019-03, Vol.18 (1), p.40-40, Article 40 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0959-5 ;PMID: 30866952

Full text available

Citations Cited by
16
Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
Material Type:
Book 		Add to My Research

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer

https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode ;ISBN: 9783038426332 ;ISBN: 3038426334 ;ISBN: 9783038426325 ;ISBN: 3038426326 ;DOI: 10.3390/books978-3-03842-633-2

Full text available

Citations Cited by
17
Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020
Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020
Material Type:
Article 		Add to My Research

Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020

BMC public health, 2023-10, Vol.23 (1), p.1974-1974, Article 1974 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/s12889-023-16888-x ;PMID: 37821858

Full text available

Citations Cited by
18
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Material Type:
Article 		Add to My Research

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258

Full text available

Citations Cited by
19
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Article 		Add to My Research

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482

Full text available

Citations Cited by
20
Trends in the incidence and mortality of cancer in Saudi Arabia
Trends in the incidence and mortality of cancer in Saudi Arabia
Material Type:
Article 		Add to My Research

Trends in the incidence and mortality of cancer in Saudi Arabia

Saudi medical journal, 2018-12, Vol.39 (12), p.1259-1262 [Peer Reviewed Journal]

COPYRIGHT 2018 Saudi Medical Journal ;Saudi Medical Journal 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial – Share Alike License http://creativecommons.org/licenses/by-nc-sa/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © Saudi Medical Journal 2018 ;ISSN: 0379-5284 ;EISSN: 1658-3175 ;DOI: 10.15537/smj.2018.12.23348 ;PMID: 30520511

Full text available

Citations Cited by

Results 1 - 20 of 1,498,556  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,196,408)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1957  (3,276)
  2. 1957 To 1973  (2,502)
  3. 1974 To 1990  (19,169)
  4. 1991 To 2008  (268,161)
  5. After 2008  (1,204,045)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,370,930)
  2. magazinearticle  (40,636)
  3. Reports  (20,467)
  4. Newspaper Articles  (19,364)
  5. Thesises (postgraduate)  (18,245)
  6. Book Chapters  (6,451)
  7. Reviews  (5,064)
  8. Books  (4,525)
  9. Newsletter Articles  (3,631)
  10. Conference Proceedings  (3,291)
  11. Web Resources  (3,191)
  12. Images  (780)
  13. Government Documents  (459)
  14. Text Resources  (420)
  15. Datasets  (393)
  16. Videos  (340)
  17. References  (152)
  18. Audio  (99)
  19. Other  (44)
  20. Standards  (41)
  21. More options open sub menu

Subject 

  1. Science & Technology  (1,003,684)
  2. Life Sciences & Biomedicine  (910,930)
  3. Humans  (645,295)
  4. Cancer  (543,659)
  5. Oncology  (455,242)
  6. Female  (334,196)
  7. Tumors  (260,417)
  8. Male  (248,215)
  9. Breast Cancer  (229,247)
  10. Middle Aged  (217,754)
  11. Aged  (180,373)
  12. Adult  (161,633)
  13. Animals  (151,274)
  14. Patients  (151,197)
  15. Cancer Research  (147,832)
  16. Chemotherapy  (147,330)
  17. Cancer Therapies  (146,182)
  18. Metastasis  (142,758)
  19. Proteins  (139,346)
  20. Care And Treatment  (135,071)
  21. More options open sub menu

Language 

  1. English  (1,458,277)
  2. Japanese  (199,686)
  3. French  (9,893)
  4. Spanish  (9,545)
  5. Portuguese  (7,190)
  6. Chinese  (6,394)
  7. German  (6,317)
  8. Korean  (3,347)
  9. Russian  (2,416)
  10. Turkish  (1,590)
  11. Persian  (1,439)
  12. Norwegian  (1,226)
  13. Polish  (1,008)
  14. Catalan  (879)
  15. Swedish  (460)
  16. Czech  (294)
  17. Croatian  (209)
  18. Italian  (202)
  19. Dutch  (173)
  20. Indonesian  (131)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait